schliessen

Filtern

 

Bibliotheken

Gastroesophageal Reflux Disease and Pulmonary Diseases Associated with Aspergillosis: Is There a Connection?

Introduction We studied the relationship between GORD and allergic bronchopulmonary aspergillosis (ABPA), chronic pulmonary aspergillosis (CPA), or Aspergillus bronchitis. Background Gastroesophageal reflux disease (GORD) is well known to initiate or exacerbate pulmonary inflammatory conditions, ind... Full description

Journal Title: Mycopathologia Dec 2017, Vol.182(11-12), pp.1125-1129
Main Author: Gamaletsou, Maria
Other Authors: Denning, David
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 0301486X ; E-ISSN: 15730832 ; DOI: 10.1007/s11046-017-0176-y
Link: http://search.proquest.com/docview/1963349761/?pq-origsite=primo
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: proquest1963349761
title: Gastroesophageal Reflux Disease and Pulmonary Diseases Associated with Aspergillosis: Is There a Connection?
format: Article
creator:
  • Gamaletsou, Maria
  • Denning, David
subjects:
  • Obstructive Lung Disease
  • Markers
  • Fungicides
  • Medical Research
  • Endoscopy
  • Males
  • Patients
  • Pain
  • Ulcers
  • Medical Services
  • Bronchitis
  • Chronic Obstructive Pulmonary Disease
  • Smoking
  • Surgery
  • Aspergillosis
  • Lung Diseases
  • Ph Effects
  • Immunoglobulin G
  • Immunoglobulin E
  • Immunoglobulins
  • Laryngoscopy
  • Females
  • Pain
  • Nausea
  • Respiration
  • Antibodies
  • Asthma
  • Medical Research
  • Bronchitis
  • Asthma
  • Nausea
  • Dyspnea
  • Dyspnea
  • Gastroesophageal Reflux
  • Serology
  • Gastroesophageal Reflux
  • Esophagus
  • Endoscopes
  • Inflammation
  • Asthma
  • Esophagus
  • Sputum
  • Medical Records
  • Smoking
  • Allergic Bronchopulmonary Aspergillosis
  • Ulcers
  • Medical Instruments
  • Pain
  • Alcoholic Beverages
  • Gastroesophageal Reflux
  • Aspergilluslung Disease
ispartof: Mycopathologia, Dec 2017, Vol.182(11-12), pp.1125-1129
description: Introduction We studied the relationship between GORD and allergic bronchopulmonary aspergillosis (ABPA), chronic pulmonary aspergillosis (CPA), or Aspergillus bronchitis. Background Gastroesophageal reflux disease (GORD) is well known to initiate or exacerbate pulmonary inflammatory conditions, inducing bronchial asthma and chronic obstructive lung disease. Methods We reviewed four patients referred with elevated Aspergillus serology markers and marked pulmonary symptoms for ABPA, CPA, and Aspergillus bronchitis, and discussed the underlying pathophysiological relationship with GORD. Data were collected retrospectively from medical records included age, gender, predisposing factors for ABPA, chronic pulmonary aspergillosis, or Aspergillus bronchitis; presence of nocturnal reflux, nausea, epigastric pain, Medical Research Council dyspnea scale score, pH manometry data, endoscopic results (ulcers, Barrett’s esophagus), treatment of GORD [proton-pump inhibitors (PPIs), surgical operation]; history of smoking, alcohol consumption; concomitant COPD; serological markers (anti-Aspergillus IgG, anti-Aspergillus IgE), and antifungal treatment. Results Four patients with GORD were studied; following PPIs administration two achieved clinical improvement. One had ABPA, one CPA, and two had Aspergillus bronchitis; median age was 57 years [range 39–71]; males-to-females ratio was 1:3. Serological markers for aspergillosis were: median total IgE antibodies 573 KIU/L [range 13.1–850], median Aspergillus IgE-specific antibodies 1.2 kAU/L [range
language: eng
source:
identifier: ISSN: 0301486X ; E-ISSN: 15730832 ; DOI: 10.1007/s11046-017-0176-y
fulltext: fulltext
issn:
  • 0301486X
  • 0301-486X
  • 15730832
  • 1573-0832
url: Link


@attributes
ID1873306941
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid1963349761
sourceidproquest
recordidTN_proquest1963349761
sourcesystemOther
pqid1963349761
galeid514449440
display
typearticle
titleGastroesophageal Reflux Disease and Pulmonary Diseases Associated with Aspergillosis: Is There a Connection?
creatorGamaletsou, Maria ; Denning, David
ispartofMycopathologia, Dec 2017, Vol.182(11-12), pp.1125-1129
identifier
subjectObstructive Lung Disease ; Markers ; Fungicides ; Medical Research ; Endoscopy ; Males ; Patients ; Pain ; Ulcers ; Medical Services ; Bronchitis ; Chronic Obstructive Pulmonary Disease ; Smoking ; Surgery ; Aspergillosis ; Lung Diseases ; Ph Effects ; Immunoglobulin G ; Immunoglobulin E ; Immunoglobulins ; Laryngoscopy ; Females ; Pain ; Nausea ; Respiration ; Antibodies ; Asthma ; Medical Research ; Bronchitis ; Asthma ; Nausea ; Dyspnea ; Dyspnea ; Gastroesophageal Reflux ; Serology ; Gastroesophageal Reflux ; Esophagus ; Endoscopes ; Inflammation ; Asthma ; Esophagus ; Sputum ; Medical Records ; Smoking ; Allergic Bronchopulmonary Aspergillosis ; Ulcers ; Medical Instruments ; Pain ; Alcoholic Beverages ; Gastroesophageal Reflux ; Aspergilluslung Disease
descriptionIntroduction We studied the relationship between GORD and allergic bronchopulmonary aspergillosis (ABPA), chronic pulmonary aspergillosis (CPA), or Aspergillus bronchitis. Background Gastroesophageal reflux disease (GORD) is well known to initiate or exacerbate pulmonary inflammatory conditions, inducing bronchial asthma and chronic obstructive lung disease. Methods We reviewed four patients referred with elevated Aspergillus serology markers and marked pulmonary symptoms for ABPA, CPA, and Aspergillus bronchitis, and discussed the underlying pathophysiological relationship with GORD. Data were collected retrospectively from medical records included age, gender, predisposing factors for ABPA, chronic pulmonary aspergillosis, or Aspergillus bronchitis; presence of nocturnal reflux, nausea, epigastric pain, Medical Research Council dyspnea scale score, pH manometry data, endoscopic results (ulcers, Barrett’s esophagus), treatment of GORD [proton-pump inhibitors (PPIs), surgical operation]; history of smoking, alcohol consumption; concomitant COPD; serological markers (anti-Aspergillus IgG, anti-Aspergillus IgE), and antifungal treatment. Results Four patients with GORD were studied; following PPIs administration two achieved clinical improvement. One had ABPA, one CPA, and two had Aspergillus bronchitis; median age was 57 years [range 39–71]; males-to-females ratio was 1:3. Serological markers for aspergillosis were: median total IgE antibodies 573 KIU/L [range 13.1–850], median Aspergillus IgE-specific antibodies 1.2 kAU/L [range <0.4–24.7], and median Aspergillus IgG titers 71 mg/L [range 20–119]. Aspergillus fumigatus grew in one sputum sample. Conclusion Clinicians caring for patients with gastroesophageal reflux disease presenting with elevated Aspergillus IgG or IgE antibodies should maintain a high index of suspicion for this association and proceed to appropriate evaluations, including laryngoscopy and endoscopy, initiating specific PPI-directed therapy when indicated.
languageeng
source
version6
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://search.proquest.com/docview/1963349761/?pq-origsite=primo$$EView_record_in_ProQuest_(subscribers_only)
search
creatorcontrib
0Gamaletsou, Maria
1Denning, David
titleGastroesophageal Reflux Disease and Pulmonary Diseases Associated with Aspergillosis: Is There a Connection?
descriptionIntroduction We studied the relationship between GORD and allergic bronchopulmonary aspergillosis (ABPA), chronic pulmonary aspergillosis (CPA), or Aspergillus bronchitis. Background Gastroesophageal reflux disease (GORD) is well known to initiate or exacerbate pulmonary inflammatory conditions, inducing bronchial asthma and chronic obstructive lung disease. Methods We reviewed four patients referred with elevated Aspergillus serology markers and marked pulmonary symptoms for ABPA, CPA, and Aspergillus bronchitis, and discussed the underlying pathophysiological relationship with GORD. Data were collected retrospectively from medical records included age, gender, predisposing factors for ABPA, chronic pulmonary aspergillosis, or Aspergillus bronchitis; presence of nocturnal reflux, nausea, epigastric pain, Medical Research Council dyspnea scale score, pH manometry data, endoscopic results (ulcers, Barrett’s esophagus), treatment of GORD [proton-pump inhibitors (PPIs), surgical operation]; history of smoking, alcohol consumption; concomitant COPD; serological markers (anti-Aspergillus IgG, anti-Aspergillus IgE), and antifungal treatment. Results Four patients with GORD were studied; following PPIs administration two achieved clinical improvement. One had ABPA, one CPA, and two had Aspergillus bronchitis; median age was 57 years [range 39–71]; males-to-females ratio was 1:3. Serological markers for aspergillosis were: median total IgE antibodies 573 KIU/L [range 13.1–850], median Aspergillus IgE-specific antibodies 1.2 kAU/L [range <0.4–24.7], and median Aspergillus IgG titers 71 mg/L [range 20–119]. Aspergillus fumigatus grew in one sputum sample. Conclusion Clinicians caring for patients with gastroesophageal reflux disease presenting with elevated Aspergillus IgG or IgE antibodies should maintain a high index of suspicion for this association and proceed to appropriate evaluations, including laryngoscopy and endoscopy, initiating specific PPI-directed therapy when indicated.
subject
0Obstructive Lung Disease
1Markers
2Fungicides
3Medical Research
4Endoscopy
5Males
6Patients
7Pain
8Ulcers
9Medical Services
10Bronchitis
11Chronic Obstructive Pulmonary Disease
12Smoking
13Surgery
14Aspergillosis
15Lung Diseases
16Ph Effects
17Immunoglobulin G
18Immunoglobulin E
19Immunoglobulins
20Laryngoscopy
21Females
22Nausea
23Respiration
24Antibodies
25Asthma
26Dyspnea
27Gastroesophageal Reflux
28Serology
29Esophagus
30Endoscopes
31Inflammation
32Sputum
33Medical Records
34Allergic Bronchopulmonary Aspergillosis
35Medical Instruments
36Alcoholic Beverages
37Aspergilluslung Disease
38Gastroesophageal reflux
39Aspergilluslung disease
general
0English
1Springer Nature B.V.
210.1007/s11046-017-0176-y
3Medical Database
4Health & Medical Collection (Alumni edition)
5Medical Database (Alumni edition)
6ProQuest Pharma Collection
7Health & Medical Collection
8ProQuest Biology Journals
9ProQuest Agriculture Journals
10Aquatic Science Journals
11Biological Science Database
12Earth, Atmospheric & Aquatic Science Database (ProQuest)
13Engineering Research Database
14Technology Research Database
15ProQuest Agricultural Science Collection
16ProQuest Aquatic Science Collection
17ProQuest Biological Science Collection
18ProQuest Central
19ProQuest Engineering Collection
20ProQuest Environmental Science Collection
21ProQuest Hospital Collection
22ProQuest Natural Science Collection
23ProQuest Technology Collection
24Hospital Premium Collection (Alumni edition)
25ProQuest SciTech Collection
26ProQuest Health & Medical Complete
27ProQuest Medical Library
28Agricultural & Environmental Science Database
29Earth, Atmospheric & Aquatic Science Database
30Natural Science Collection
31ProQuest Central (new)
32ProQuest Central K-12
33ProQuest Central Korea
34SciTech Premium Collection
35Health Research Premium Collection
36Health Research Premium Collection (Alumni edition)
37ProQuest Central Essentials
38ProQuest Central China
39ProQuest One Academic
40Environmental Science Index (ProQuest)
41Biological Science Index (ProQuest)
42Environmental Science Collection (ProQuest)
sourceidproquest
recordidproquest1963349761
issn
00301486X
10301-486X
215730832
31573-0832
rsrctypearticle
creationdate2017
addtitleMycopathologia
searchscope
01000273
11006761
21006762
31006772
41006815
51007067
61007108
71007160
81007530
91007531
101007845
111007856
121007945
131008886
141009127
151009386
161009715
1710000004
1810000005
1910000006
2010000013
2110000015
2210000022
2310000035
2410000036
2510000038
2610000039
2710000041
2810000043
2910000047
3010000050
3110000053
3210000118
3310000119
3410000120
3510000155
3610000156
3710000157
3810000158
3910000164
4010000198
4110000200
4210000209
4310000217
4410000234
4510000238
4610000244
4710000253
4810000255
4910000256
5010000257
5110000258
5210000260
5310000268
5410000270
5510000271
5610000281
5710000300
5810000302
5910000348
6010000349
6110000350
6210000354
6310000360
64proquest
scope
01000273
11006761
21006762
31006772
41006815
51007067
61007108
71007160
81007530
91007531
101007845
111007856
121007945
131008886
141009127
151009386
161009715
1710000004
1810000005
1910000006
2010000013
2110000015
2210000022
2310000035
2410000036
2510000038
2610000039
2710000041
2810000043
2910000047
3010000050
3110000053
3210000118
3310000119
3410000120
3510000155
3610000156
3710000157
3810000158
3910000164
4010000198
4110000200
4210000209
4310000217
4410000234
4510000238
4610000244
4710000253
4810000255
4910000256
5010000257
5110000258
5210000260
5310000268
5410000270
5510000271
5610000281
5710000300
5810000302
5910000348
6010000349
6110000350
6210000354
6310000360
64proquest
lsr43
01000273true
11006761true
21006762true
31006772true
41006815true
51007067true
61007108true
71007160true
81007530false
91007531false
101007845true
111007856true
121007945true
131008886true
141009127true
151009386true
161009715true
1710000004false
1810000005false
1910000006false
2010000013false
2110000015false
2210000022false
2310000035true
2410000036true
2510000038true
2610000039true
2710000041false
2810000043false
2910000047true
3010000050true
3110000053false
3210000118true
3310000119true
3410000120true
3510000155true
3610000156true
3710000157true
3810000158true
3910000164true
4010000198false
4110000200false
4210000209false
4310000217false
4410000234true
4510000238true
4610000244true
4710000253true
4810000255true
4910000256true
5010000257true
5110000258true
5210000260true
5310000268true
5410000270true
5510000271true
5610000281true
5710000300true
5810000302true
5910000348true
6010000349false
6110000350false
6210000354false
6310000360true
startdate20171201
enddate20171201
citationpf 1125 pt 1129 vol 182 issue 11-12
lsr30VSR-Enriched:[galeid, pqid]
sort
titleGastroesophageal Reflux Disease and Pulmonary Diseases Associated with Aspergillosis: Is There a Connection?
authorGamaletsou, Maria ; Denning, David
creationdate20171201
lso0120171201
facets
frbrgroupid-4717467853820065566
frbrtype5
newrecords20171115
languageeng
creationdate2017
topic
0Obstructive Lung Disease
1Markers
2Fungicides
3Medical Research
4Endoscopy
5Males
6Patients
7Pain
8Ulcers
9Medical Services
10Bronchitis
11Chronic Obstructive Pulmonary Disease
12Smoking
13Surgery
14Aspergillosis
15Lung Diseases
16Ph Effects
17Immunoglobulin G
18Immunoglobulin E
19Immunoglobulins
20Laryngoscopy
21Females
22Nausea
23Respiration
24Antibodies
25Asthma
26Dyspnea
27Gastroesophageal Reflux
28Serology
29Esophagus
30Endoscopes
31Inflammation
32Sputum
33Medical Records
34Allergic Bronchopulmonary Aspergillosis
35Medical Instruments
36Alcoholic Beverages
37Aspergilluslung Disease
collection
0Medical Database
1Health & Medical Collection (Alumni edition)
2Medical Database (Alumni edition)
3ProQuest Pharma Collection
4Health & Medical Collection
5ProQuest Biology Journals
6ProQuest Agriculture Journals
7Aquatic Science Journals
8Biological Science Database
9Earth, Atmospheric & Aquatic Science Database (ProQuest)
10Engineering Research Database
11Technology Research Database
12ProQuest Agricultural Science Collection
13ProQuest Aquatic Science Collection
14ProQuest Biological Science Collection
15ProQuest Central
16ProQuest Engineering Collection
17ProQuest Environmental Science Collection
18ProQuest Hospital Collection
19ProQuest Natural Science Collection
20ProQuest Technology Collection
21Hospital Premium Collection (Alumni edition)
22ProQuest SciTech Collection
23ProQuest Health & Medical Complete
24ProQuest Medical Library
25Agricultural & Environmental Science Database
26Earth, Atmospheric & Aquatic Science Database
27Natural Science Collection
28ProQuest Central (new)
29ProQuest Central K-12
30ProQuest Central Korea
31SciTech Premium Collection
32Health Research Premium Collection
33Health Research Premium Collection (Alumni edition)
34ProQuest Central Essentials
35ProQuest Central China
36ProQuest One Academic
37Environmental Science Index (ProQuest)
38Biological Science Index (ProQuest)
39Environmental Science Collection (ProQuest)
prefilterarticles
rsrctypearticles
creatorcontrib
0Gamaletsou, Maria
1Denning, David
jtitleMycopathologia
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Gamaletsou
1Denning
aufirst
0Maria
1David
au
0Gamaletsou, Maria
1Denning, David
atitleGastroesophageal Reflux Disease and Pulmonary Diseases Associated with Aspergillosis: Is There a Connection?
jtitleMycopathologia
risdate20171201
volume182
issue11-12
spage1125
epage1129
pages1125-1129
issn0301486X
eissn15730832
formatjournal
genrearticle
ristypeJOUR
abstractIntroduction We studied the relationship between GORD and allergic bronchopulmonary aspergillosis (ABPA), chronic pulmonary aspergillosis (CPA), or Aspergillus bronchitis. Background Gastroesophageal reflux disease (GORD) is well known to initiate or exacerbate pulmonary inflammatory conditions, inducing bronchial asthma and chronic obstructive lung disease. Methods We reviewed four patients referred with elevated Aspergillus serology markers and marked pulmonary symptoms for ABPA, CPA, and Aspergillus bronchitis, and discussed the underlying pathophysiological relationship with GORD. Data were collected retrospectively from medical records included age, gender, predisposing factors for ABPA, chronic pulmonary aspergillosis, or Aspergillus bronchitis; presence of nocturnal reflux, nausea, epigastric pain, Medical Research Council dyspnea scale score, pH manometry data, endoscopic results (ulcers, Barrett’s esophagus), treatment of GORD [proton-pump inhibitors (PPIs), surgical operation]; history of smoking, alcohol consumption; concomitant COPD; serological markers (anti-Aspergillus IgG, anti-Aspergillus IgE), and antifungal treatment. Results Four patients with GORD were studied; following PPIs administration two achieved clinical improvement. One had ABPA, one CPA, and two had Aspergillus bronchitis; median age was 57 years [range 39–71]; males-to-females ratio was 1:3. Serological markers for aspergillosis were: median total IgE antibodies 573 KIU/L [range 13.1–850], median Aspergillus IgE-specific antibodies 1.2 kAU/L [range <0.4–24.7], and median Aspergillus IgG titers 71 mg/L [range 20–119]. Aspergillus fumigatus grew in one sputum sample. Conclusion Clinicians caring for patients with gastroesophageal reflux disease presenting with elevated Aspergillus IgG or IgE antibodies should maintain a high index of suspicion for this association and proceed to appropriate evaluations, including laryngoscopy and endoscopy, initiating specific PPI-directed therapy when indicated.
copDordrecht
pubSpringer Nature B.V.
doi10.1007/s11046-017-0176-y
urlhttp://search.proquest.com/docview/1963349761/
date2017-12-01